FindTrial
Sign In

Study to Find Out if Heartbeat Changes Can Help Choose the Right Treatment for Anxiety

A study of Heart rate Variability for Prediction of Response to Selective Serotonin Reuptake Inhibitor (SSRI) & Selective partial Agonist and Reuptake Inhibitor (SPARI) in Generalised Anxiety Disorder - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091034
Enrollment
60
Registered
2025-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

Intervention1: NIL: NIL Intervention2: Nil: Nil Control Intervention1: NIL: NIL

Sponsors

Daniyal Farooque
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients of generalized anxiety disorder with moderate or severe anxiety based on Hamilton anxiety rating scale (HAM-A)

Exclusion criteria

Exclusion criteria: Any physical or psychiatric co-morbidity except insomnia Patient with heart disease or taking any heart rate controlling drugs like beta blockers. Pregnancy Patient with pacemaker implant. Severe systemic disease, cardiopulmonary or kidney insufficiency

Design outcomes

Secondary

MeasureTime frame
NILTimepoint: NIL—

Primary

MeasureTime frame
Heart Rate VariabilityTimepoint: 1. Baseline 2. After 8 weeks of treatment—

Countries

India

Contacts

Public ContactGul Ar Navi Khan

Jawaharlal Nehru Medical College, Aligarh Muslim University

dr.gular@rediffmail.com8630948761

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026